Published in World J Biol Psychiatry on July 01, 2012
Squaring the circle? On the search for circulating biomarkers in polygenic psychiatric disorders. Eur Child Adolesc Psychiatry (2014) 0.83
Driving and attention deficit hyperactivity disorder. J Neural Transm (Vienna) (2015) 0.78
Decreased binding capacity (Bmax) of muscarinic acetylcholine receptors in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD). Atten Defic Hyperact Disord (2013) 0.76
The Development of an Embedded Figures Test for the Detection of Feigned Attention Deficit Hyperactivity Disorder in Adulthood. PLoS One (2016) 0.75
Biomarkers in Child Mental Health: a bio-psycho-social perspective is needed. Behav Brain Funct (2015) 0.75
The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures. J Child Adolesc Psychopharmacol (2016) 0.75
The potential of biomarkers in psychiatry: focus on proteomics. J Neural Transm (Vienna) (2013) 0.75
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2008) 2.04
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry (2009) 1.64
Source localization (LORETA) of the error-related-negativity (ERN/Ne) and positivity (Pe). Brain Res Cogn Brain Res (2004) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol (2008) 1.62
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol (2008) 1.51
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J Neurochem (2005) 1.51
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
[Association of atopic eczema and attention-deficit/hyperactivity disorder - meta-analysis of epidemiologic studies]. Z Kinder Jugendpsychiatr Psychother (2013) 1.46
Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol (2002) 1.45
The relevance of iron in the pathogenesis of Parkinson's disease. Ann N Y Acad Sci (2004) 1.42
Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem (2007) 1.37
Neural response to reward anticipation is modulated by Gray's impulsivity. Neuroimage (2009) 1.27
The relevance of iron in the pathogenesis of Parkinson's disease. J Neurochem (2011) 1.26
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (2010) 1.24
A common neural basis for receptive and expressive communication of pleasant facial affect. Neuroimage (2005) 1.24
Integrating neurobiological markers of depression. Arch Gen Psychiatry (2010) 1.24
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem (2006) 1.23
Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci (2005) 1.23
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord (2005) 1.23
Empathy in children with autism and conduct disorder: group-specific profiles and developmental aspects. J Child Psychol Psychiatry (2011) 1.23
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett (2002) 1.22
Genes associated with Parkinson syndrome. J Neurol (2008) 1.21
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener Dis (2004) 1.21
Simulation of near-infrared light absorption considering individual head and prefrontal cortex anatomy: implications for optical neuroimaging. PLoS One (2011) 1.21
Hunger and satiety in anorexia nervosa: fMRI during cognitive processing of food pictures. Brain Res (2006) 1.19
Early-stage face processing dysfunction in patients with schizophrenia. Am J Psychiatry (2004) 1.16
The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.16
Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann Neurol (2003) 1.15
Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex (2006) 1.14
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS One (2010) 1.13
A molecular signature in blood identifies early Parkinson's disease. Mol Neurodegener (2012) 1.13
Developmental comorbidity in attention-deficit/hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.13
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet (2013) 1.11
Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) (2006) 1.11
High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry (2013) 1.10
Functional near-infrared spectroscopy: a long-term reliable tool for measuring brain activity during verbal fluency. Neuroimage (2008) 1.10
Application of functional near-infrared spectroscopy in psychiatry. Neuroimage (2013) 1.10
Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 1.09
Effects of gum chewing on memory and attention: reply to Scholey (2004). Appetite (2004) 1.08
"Subcellular proteomics" of neuromelanin granules isolated from the human brain. Mol Cell Proteomics (2005) 1.08
Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res (2008) 1.08
Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int J Neuropsychopharmacol (2011) 1.07
Executive functions in children with dyslexia. Dyslexia (2005) 1.07
The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol (2004) 1.07
Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis (2010) 1.07
Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum Brain Mapp (2009) 1.06
DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology (2006) 1.06
Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry (2009) 1.06
Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci (2003) 1.05
Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci (2007) 1.05
The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus. World J Biol Psychiatry (2007) 1.05
Diminished cooperativeness of psychopaths in a prisoner's dilemma game yields higher rewards. J Abnorm Psychol (2008) 1.04
Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp Brain Res (2003) 1.04
Phenotypic and measurement influences on heritability estimates in childhood ADHD. Eur Child Adolesc Psychiatry (2010) 1.04
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics. J Neural Transm (Vienna) (2011) 1.04
Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol (2004) 1.04
Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci (2007) 1.04
Perineuronal nets potentially protect against oxidative stress. Exp Neurol (2004) 1.03
Neuroprotective strategies in Parkinson's disease : an update on progress. CNS Drugs (2003) 1.02
Allelic variation of serotonin transporter function modulates the brain electrical response for error processing. Neuropsychopharmacology (2004) 1.02
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics (2006) 1.02
Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem (2006) 1.01
Botulinum toxin's axonal transport from periphery to the spinal cord. Neurochem Int (2012) 1.01
Heart rate variability and methylphenidate in children with ADHD. Atten Defic Hyperact Disord (2012) 1.01
Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA (2009) 1.00
Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch Biochem Biophys (2007) 1.00
Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells (2005) 1.00
Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder--a postmortem study. Psychiatry Res (2007) 1.00
Risky behavior in gambling tasks in individuals with ADHD--a systematic literature review. PLoS One (2013) 1.00
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease. Neurochem Int (2006) 0.99
Vigilance and sustained attention in children and adults with ADHD. J Atten Disord (2008) 0.99